Etamivan

Etamivan
Clinical data
Trade names Analepticon
ATC code R07AB04 (WHO)
Identifiers
CAS Number 304-84-7
PubChem (CID) 9363
DrugBank DB08989 YesY
ChemSpider 8996
UNII M44O63YPV9 YesY
KEGG D04080 YesY
ECHA InfoCard 100.005.599
Chemical and physical data
Formula C12H17NO3
Molar mass 223.268 g/mol
3D model (Jmol) Interactive image
  (verify)

Etamivan (INN, or ethamivan (USAN); trade names Analepticon and Vandid) is a respiratory stimulant drug[1] related to nikethamide. It was mainly used in the treatment of barbiturate overdose[2] and chronic obstructive pulmonary disease,[3] but has now largely fallen into disuse.

See also

References

  1. Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
  2. Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
  3. Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.


This article is issued from Wikipedia - version of the 9/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.